ICON Joins Groundbreaking Genome Initiative

Brendan Buckley, chief medical officer for ICON.

By Julia Brodsky, Editorial Assistant
April / May 2016

ICON plc was recently selected by Genomics England to support their “100,000 Genomes” project, the world’s largest genome sequencing project for cancer and rare diseases, which could revolutionize the diagnosis and treatment of various cancers and rare diseases.

Announced by British Prime Minister David Cameron in 2012, the project will compile 100,000 whole genomes from 70,000 individual National Health Service (N.H.S.) patients and their families. This data, once sequenced and de-identified, will become available to approved researchers who will assist in developing tools for diagnosis and treatment based on individual patients’ genetic characteristics. It is currently the largest project of its kind worldwide.

ICON, a company that offers drug development solutions to the medical industries, is headquartered in Dublin and will use its substantial data management capabilities to support and organize the clinical data collected from the 70,000 patients and their families.

“Our partnership with Genomics England demonstrates our commitment to partnering with industry and government organizations in new and innovative ways to improve patient care by accelerating the development of targeted and personalized medicines that tackle complex diseases,” said Professor Brendan Buckley, ICON’s Chief Medical Officer (left).

Managing Director for the 100,000 Genomes project, James Peach, was equally enthusiastic about the partnership. “We are delighted to be partnering with ICON,” he said.

“Their renowned expertise in data management will be fundamental in driving scientific research and accelerating the return of results for N.H.S. patients.” ♦

Leave a Reply




Share



More Articles

2018 Healthcare
and Life Sciences 50

Every year, Irish America magazine is proud to present the Healthcare and Life Sciences 50, a celebration of the...

More

Galway Start-Up Offers New Remedy for Arthritis

Loci Orthopaedics, a Galway-based medical devices start-up that has developed a new joint implant to treat arthritis,...

More

William Campbell’s Nobel Prize

Donegal native Dr. William Campbell was awarded the Nobel Prize in medicine for his work on a drug that fights...

More

Ciarán Murray

Ciarán Murray is the chief executive officer of ICON Plc., a global leader in clinical research and one of Ireland’s...

More